Recombinant human insulin (Tonghua Dongbao Pharmaceutical)

重组人胰岛素（通化东宝）

Report date: 2023/02/03 13:41:25

Base Information

Drug NameRecombinant human insulin (Tonghua Dongbao Pharmaceutical)
Drug Alias Name重组人胰岛素生物仿制药（通化东宝）重组人胰岛素生物类似药（通化东宝）常规重组人胰岛素（通化东宝）甘舒霖甘舒霖R
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTonghua Dongbao Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRechon Life Science AbTonghua Dongbao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A